The activated Akt promotes the phosphorylation of cyclin-inhibitory proteins P21 and P27, rendering them incapable of binding and inhibiting the action of the cyclin/CDK complex, with the promotion of tumor cell proliferation. The gene discussed is AKT1; the disease is neoplasm.